Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
ATAI Life Sciences N.V.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 09/29/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results |
| 05/31/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Releasees” and individually as a “Releasee”), of and from all demands, actions, causes of action, suits, covenants, contracts, controversies, agreements, promises, sums of money, accounts, bills, reckonings, damages and any and all other claims, counterclaims, defenses, rights of set-off, demands and liabilities whatsoever of every name and nature, known or unknown, suspected or unsuspected, both at law and in equity, which such Loan Party, or any of its successors, assigns, or other legal representatives may now or hereafter own, hold, have or claim to have against the Releasees or any of them for, upon, or by reason of any circumstance, action, cause or thing whatsoever which arises at any time prior to the execution of this Amendment, for or on account of, or in relation to, or in any w..." |
|
| 05/17/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/14/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/24/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/24/2023 |
8-K
| Quarterly results |
| 02/10/2023 |
SC 13G/A
| Apeiron Investment Group Ltd. reports a 19.4% stake in ATAI Life Sciences N.V. |
| 11/08/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/14/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 09/19/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 09/09/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/15/2022 |
8-K
| Quarterly results |
| 08/15/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/01/2022 |
8-K
| Unregistered Sales of Equity Securities Interactive Data |
| 07/12/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/01/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 06/17/2022 |
8-K
| Quarterly results |
| 05/27/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/16/2022 |
8-K
| Quarterly results |
| 04/29/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/18/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/30/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/30/2022 |
8-K
| Quarterly results |
| 03/01/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2022 |
SC 13G
| Apeiron Investment Group Ltd. reports a 19.7% stake in ATAI Life Sciences N.V. |
| 12/15/2021 |
8-K
| Quarterly results |
|
|
|